Illumina Receives FDA Premarket Clearance for MiSeqDx System
November 19, 2013 at 18:44 PM EST
Illumina (NASDAQ: ILMN ) today announced that it received premarket clearance from the U.S. Food and Drug Administration (FDA) for the MiSeqDx system, the first high-throughput DNA sequencing analyzer to
